Table 1.
Composite of morbidity endpoints in relation to tertile distribution of the post-CPB HMGB1 concentration.
| Total(n = 250) | First Tertile (n = 83)(0.337–2.684 ng/ml) | Second Tertile (n = 83)(2.689–5.770 ng/ml) | Third tertile (n = 84)(5.799–28.552 ng/ml) | P value | |
|---|---|---|---|---|---|
| HMGB1, ng/ml | 3.933 [2.018–6.866] | 1.734 [1.088–2.019] | 3.922 [3.209–4.500]* | 8.443 [6.829–12.029]*† | <0.001 |
| Composite morbidity, n (%) | 58 (23) | 10 (12) | 20 (24)* | 28 (33)* | 0.005 |
| Death, n (%) | 10 (4) | 0 (0) | 4 (5) | 6 (7) | 0.039 |
| Stroke, n (%) | 4 (2) | 2 (2) | 2 (2) | 0 (0) | 0.401 |
| Myocardial infarction, n (%) | 0 (0) | — | |||
| Renal failure, n (%) | 29 (12) | 2 (2) | 9 (11) | 18 (21)* | <0.001 |
| Prolonged ventilation> 24 h | |||||
| Number, n (%) | 33 (13) | 7 (8) | 11 (13) | 15 (18) | 0.205 |
| Duration (hrs) | 17 [14–21] | 18 [13–21] | 17 [13–20] | 17 [15–22] | 0.786 |
Values are expressed as the numbers of patients (%), median [interquartile range]. *P < 0.05 vs. first tertile; †P < 0.05 vs. second tertile.
CPB = cardiopulmonary bypass; HMGB1 = high mobility group box 1.